Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NantCell
Culver City, California, United Statesnantworks.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
NantCell has developed a broad immunotherapy pipeline targeting multiple tumor types using antibody, T cell, NK cell, cytokine fusion protein, mRNA, and vaccine modalities. The company’s lead program "Nogapendekin alfa inbakicept-pmln" received approval for non-muscle invasive bladder cancer. Other programs are advancing through Phase I/II clinical trials targeting solid tumors and infectious diseases. The company leverages advanced omics analytics to personalize therapy selection based on tumor proteomic/genomic profiles.[1][2][5][6]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Monoclonal antibodiesFusion proteinsCytokinesmRNA-based therapiesRecombinant vector vaccinesTherapeutic and prophylactic vaccinesChimeric Antigen Receptor (CAR) T cells and NK cells[1][2][5][6]
- Industry
- Biotech
02
Partnerships
Amgen – exclusive rights deal for AMG479/Ganitumab monoclonal antibody except Japan [1].Celgene – investment partnership announced January 2019 [2].Key collaborations within the broader NantWorks ecosystem.
Beyond the preview
Go deeper on NantCell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NantCell.